Foresite Capital Management V LLC purchased a new stake in Disc Medicine Opco Inc (NASDAQ:IRON – Get Rating) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 243,513 shares of the company’s stock, valued at approximately $4,843,000. Disc Medicine Opco accounts for approximately 3.8% of […]
Hims & Hers Health (NYSE:HIMS – Get Rating) had its price objective cut by equities researchers at Piper Sandler from $12.00 to $11.00 in a research note issued on Tuesday, The Fly reports. Piper Sandler’s target price points to a potential upside of 23.04% from the company’s current price. Several other research analysts have also […]
Kinnate Biopharma (NASDAQ:KNTE – Get Rating)‘s stock had its “maintains” rating reaffirmed by research analysts at 500.com in a research report issued on Thursday, Benzinga reports. Other analysts also recently issued reports about the company. The Goldman Sachs Group decreased their price target on Kinnate Biopharma from $29.00 to $26.00 and set a “buy” rating […]
Equities researchers at Raymond James initiated coverage on shares of Disc Medicine Opco (NASDAQ:IRON – Get Rating) in a research note issued on Tuesday, The Fly reports. The brokerage set an “outperform” rating on the stock. Several other equities analysts have also recently weighed in on the company. SVB Securities assumed coverage on Disc Medicine […]
Hims & Hers Health (NYSE:HIMS – Get Rating) had its target price lifted by Piper Sandler from $11.00 to $12.00 in a research report sent to investors on Tuesday, The Fly reports. A number of other equities analysts have also weighed in on the stock. Citigroup lifted their price target on shares of Hims & […]